Microbio Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 10, 2020 at 05:36 pm EDT
Share
Microbio Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was TWD 391.693 million compared to TWD 348.750 million a year ago. Operating loss was TWD 56.327 million compared to TWD 43.911 million a year ago. Net income was TWD 2,089.889 million compared to net loss of TWD 139.902 million a year ago. Basic earnings per share was TWD 5.32 compared to basic loss per share of TWD 0.34 a year ago. Diluted earnings per share was TWD 5.31 compared to diluted loss per share of TWD 0.34 a year ago. For the half year, total revenue was TWD 808.327 million compared to TWD 695.987 million a year ago. Operating loss was TWD 75.220 million compared to TWD 76.493 million a year ago. Net income was TWD 1,911.337 million compared to net loss of TWD 148.296 million a year ago. Basic earnings per share was TWD 4.82 compared to basic loss per share of TWD 0.36 a year ago. Diluted earnings per share was TWD 4.81 compared to diluted loss per share of TWD 0.36 a year ago.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 